ClinicalTrials.gg
CompletedNCT07218965(FARM-TOK)Updated Nov 4, 2026

Fostering Agricultural Relationships and Meaning - Thriving on Kinship

An interventional study of Cognitive-Behavioral Therapy for Perceived Social Isolation and Health Education in Loneliness, Social Isolation and Rural Health, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Ohio State University · Not applicable, Interventional, and Treatment

Updated Nov 4, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 97 studies in Social Isolation with a site in United States — 26 open to participants now, 29 under way, none of them phase 3. Social Isolation · United States.

Enrollment
74th of 92
31 · median 79
Started
2025
with 8 others
No phase
89 of 97
24 open now
Registered
88th of 97
by date

Among the 97 studies in Social Isolation with a site in United States, this one is the 74th largest by enrollment of the 92 interventional ones that give a count, is one of 9 that started in 2025, is one of 89 with no phase, and was the 88th registered.

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's enrollment of 31 is below the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Open to participants now

26 of the 97 studies in Social Isolation with a site in United States are open now, in 4 countries. Each count lists the studies.

All 26 open studies →

Who these studies take

Of the 34 Social Isolation studies recruiting now, 22 (65%) set no upper age limit and 6 (18%) stop at 75 or younger; 4 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies in Social Isolation with a site in United States, or all of them as a file.
02

Study summary

This study aims to enroll 65 participants who will be assigned to one of two groups. Each group will receive an intervention consisting of six weekly sessions of 40-60 minutes each. Eligibility includes residing in an agricultural area and reporting loneliness or feeling alone or disconnected.

Read the detailed description

Individuals (n = 65) who reside in a agricultural area and report loneliness will be randomized to either (1) therapist-delivered cognitive-behavioral therapy for perceived social isolation, or (2) therapist-delivered Health Education. Loneliness, quantity of social interactions, perceived social support, substance use outcomes, and other key outcomes and descriptive characteristics will be assessed at baseline, mid-treatment, post-treatment, and at a one-month follow-up. Participants will have the option to complete daily ecological momentary assessments (EMA) 3 times a day for 7 weeks via an app on their smartphone, Catalyst by MetricWire, throughout the intervention period.

03

Conditions studied

  • Loneliness
  • Social Isolation
  • Rural Health

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older
  • able to provide
  • understand English
  • have internet access
  • reside in an agricultural area
  • screen positive for loneliness by scoring at least 44 on the 20-item UCLA Loneliness Scale

Exclusion criteria

Exclusion Criteria:

  • unable to give
  • non-English speaking
  • does not have consistent access to a phone and/or internet
  • reports being diagnosed with a neurological disorder or a current psychotic or bipolar 1 diagnosis
  • current suicidal or homicidal intent indicating a need for immediate hospitalization or treatment as determined by clinical interviewer
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Cognitive-Behavioral Therapy

    CBT delivered over the course of 6, \~45 minute sessions delivered via telehealth

    Behavioral: Cognitive-Behavioral Therapy for Perceived Social Isolation

  • Active comparator
    Therapist-delivered Health Education

    Health education sessions delivered over the course of 6, \~45 minute sessions delivered via telehealth.

    Behavioral: Health Education

Interventions

  • BehavioralCognitive-Behavioral Therapy for Perceived Social Isolation

    Consists of six sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use.

    Also known as: CBT-PSI

  • BehavioralHealth Education

    Health education provides information on the importance and benefits of and guidelines for living a health lifestyle.

    Also known as: HET

06

What researchers measure

Primary outcomes

  1. Mean change in loneliness

    Loneliness will be measured using the UCLA Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.

    Time frame: Baseline to 6 months

  2. Mean change in anxiety

    Anxiety will be measured using the PROMIS tool. The scores range from 4-20 with higher scores indicating worse outcome.

    Time frame: Baseline to 6 months

  3. Mean change in depression

    Depression will be measured using the PROMIS tool. The scores range from 4-20 with higher scores indicating worse outcome.

    Time frame: Baseline to 6 months

  4. Mean change in social interactions

    Duke Social Support Index assesses several domains of perceived social support, including social network size, social interaction, social satisfaction, and instrumental social support. Higher scores indicate a higher quality of social interactions. Scores range from 0 to 37.

    Time frame: Baseline to 6 months

07

Study locations

1 site
  • The Ohio State University Department of Psychiatry and Behavioral Health
    Columbus, Ohio 43210, United States
08

References and documents

Individual participant data

Plan to share: Yes — All de-identified demographic and clinical data collected as part of this project will be available as raw individual level data for sharing with external researchers working at an institution with a Federalwide Assurance (FWA) for the Protection of Human Subjects. Data will therefore be available for secondary analytic purposes. Names and institutions of persons either given or denied access to data will be tracked by our Administrative Core and will be available upon request from the sponsor. Data will not be available for data sharing until after this project is complete and the primary outcomes are published.

Supporting information: Study protocol

Time frame: Data requests can be submitted starting 9 months after article publication and the data will be made accessible for at least the next two years. Extensions will be considered on a case-by-case basis.

Access criteria: Access to trial individual participant data (IPD) can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Sep 2026, 13 months.

Of 155 non-industry interventional studies with no phase under Social Isolation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's 13 months is below that.

Counting every sponsor, half of 156 studies reached it within 18 months; a quarter within 10 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Jul 2026 → Sep 2026 and completion Jul 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2025
First posted
Oct 21, 2025
StartActual
Jul 26, 2025
Primary completionActual
Sep 6, 2026was Jul 2026
CompletionActual
Sep 6, 2026was Jul 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 4, 2026
Primary completion
Jul 2026→Sep 6, 2026 (actual)
Nov 4, 2026
Study completion
Jul 2026→Sep 6, 2026 (actual)
Nov 4, 2026
Enrollment
65 (estimated)→31 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Completed
    Primary completion Jul 2026→Sep 6, 2026 (now actual)
    Study completion Jul 2026→Sep 6, 2026 (now actual)
    Enrollment 65 (estimated)→31 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07218965
Responsible party
Nicholas Allan (Assistant Professor, Ohio State University) — Principal investigator
First posted
Oct 21, 2025
Start date
Jul 26, 2025
Primary completion
Sep 6, 2026
Completion
Sep 6, 2026
Last update
Nov 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion